Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
How do chemical exposures trigger autoimmune diseases?
The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...
Synthesis of a Kidney Cancer Drug
We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...
Managing Life with Chronic Urine Leakage and Stigma: What Do Women in Ghana Think About an Innovation to Support Coping?
Women with obstetric fistula experience chronic leaking urine, leading to stigma, isolation, and loss of...